World Solve

Many patients with chronic conditions end up back in the hospital shortly after being discharged, often due to gaps in follow-up care rather than a failure of the original treatment. Better post-discharge support remains an unresolved healthcare system issue.

Patients who've had one dangerous blood clot are at ongoing risk of another, and current prevention relies mainly on long-term blood thinners that carry their own risks. A more targeted, lower-risk prevention method remains needed.

Many cancer survivors continue to experience pain long after their cancer treatment concludes, and this pain is often undertreated because it's assumed to have resolved along with the disease. Better long-term pain management for survivors remains an overlooked need.

A meaningful share of infertility cases have no identifiable cause even after thorough testing, leaving both patients and doctors without clear answers or targeted treatment. Understanding these cases better remains an open research priority.

Childhood asthma rates have risen substantially, but why some children develop severe, persistent symptoms while others exposed to similar triggers don't remains only partly understood. A clearer answer could improve both prevention and treatment.

Some patients continue experiencing symptoms long after completing standard treatment for Lyme disease, and doctors disagree on both the cause and the best way to treat this lingering illness. Resolving this uncertainty remains a significant unmet need.

Post-viral fatigue syndromes, including long COVID, leave some patients exhausted for months or years after the initial infection has cleared, and the biological mechanism remains unclear. Understanding this could unlock treatment for a currently poorly understood condition.

Repeated gout attacks can cause lasting joint damage even with treatment, and prevention still relies mainly on managing uric acid levels rather than fully eliminating the underlying risk. A more definitive prevention method remains unmet.

Narcolepsy causes sudden, uncontrollable sleep episodes that significantly disrupt daily life, and current treatments manage symptoms rather than address the underlying cause. A true cure remains undiscovered.

This parasitic disease affects millions in tropical and subtropical regions, but effective treatment remains expensive, difficult to access, or logistically challenging for many affected communities. Closing this access gap remains unresolved.

Diabetic retinopathy remains a leading cause of blindness among working-age adults, and while treatment can slow progression, prevention before damage begins remains incomplete. Earlier, more effective prevention could protect vision for millions of diabetics.

Malnutrition rates spike dramatically in areas affected by war, but delivering treatment consistently in unstable, hard-to-reach regions remains a persistent logistical and medical challenge. Solving this requires both medical and access innovation.

Persistent dizziness and balance problems can severely affect quality of life, yet treatment for many chronic cases remains limited and inconsistent. A more reliable, targeted treatment approach remains undeveloped.

Even with strict sterile procedures, a portion of surgical patients still develop infections afterward, extending recovery and sometimes causing serious complications. Reducing this risk further remains an ongoing surgical challenge.

Highly effective hepatitis C treatments exist, but cost and healthcare access still prevent many infected people worldwide from receiving them. Expanding affordable access remains the primary barrier rather than the science itself.

COPD gradually reduces lung function over years, and while treatment can ease symptoms and slow decline, it can't reverse the underlying lung damage. A cure remains out of reach for the millions living with this condition.

Even when people successfully lose significant weight, the body's biology often works to regain it over time, undermining long-term success. Understanding and countering this biological pushback remains a major open challenge.

Chronic pelvic pain often has no clearly identifiable cause even after extensive testing, leaving many patients with limited treatment options. A deeper understanding of its underlying causes remains needed.

Cervical cancer remains highly preventable through regular screening, but many women in lower-resource regions lack consistent access to the tests that catch it early. Closing this access gap could prevent large numbers of otherwise preventable deaths.

Many people with chronic insomnia end up relying on sleep medication for years, since non-drug treatments don't work consistently for everyone. A more effective, sustainable solution remains an open need.